Racial Disparities in Patients with Myelodysplastic Syndrome (MDS): is There Really a Difference?
Little is known about racial disparities amongst patients with MDS. The incidence of MDS is higher in Caucasians, who represent the majority of patients included on clinical trials. We explored the differences in disease features and outcomes between Caucasians, African Americans (AA), and Hispanics.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Hanadi Ramadan, Amanda Cameron, Najla Al Ali, Eric Padron, David Sallman, Jeffrey Lancet, Alan List, Rami Komrokji Source Type: research
More News: African Health | Clinical Trials | Hematology | Leukemia | Lymphoma | Myelodysplastic Syndrome | Myeloma